BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27712778)

  • 1. Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance.
    Raphael CE; Cooper R; Parker KH; Collinson J; Vassiliou V; Pennell DJ; de Silva R; Hsu LY; Greve AM; Nijjer S; Broyd C; Ali A; Keegan J; Francis DP; Davies JE; Hughes AD; Arai A; Frenneaux M; Stables RH; Di Mario C; Prasad SK
    J Am Coll Cardiol; 2016 Oct; 68(15):1651-1660. PubMed ID: 27712778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.
    Bietenbeck M; Florian A; Shomanova Z; Meier C; Yilmaz A
    Clin Res Cardiol; 2018 Nov; 107(11):1062-1070. PubMed ID: 29774406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy.
    Malahfji M; Senapati A; Debs D; Angulo C; Zhan Y; Nagueh SF; Shah DJ
    Sci Rep; 2020 Sep; 10(1):15977. PubMed ID: 32994462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
    Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systolic compression of epicardial coronary and intramural arteries in children with hypertrophic cardiomyopathy.
    Mohiddin SA; Fananapazir L
    Tex Heart Inst J; 2002; 29(4):290-8. PubMed ID: 12484613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
    Cannon RO; Rosing DR; Maron BJ; Leon MB; Bonow RO; Watson RM; Epstein SE
    Circulation; 1985 Feb; 71(2):234-43. PubMed ID: 4038383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional difference of microcirculation in patients with asymmetric hypertrophic cardiomyopathy: transthoracic Doppler coronary flow velocity reserve analysis.
    Tesic M; Djordjevic-Dikic A; Beleslin B; Trifunovic D; Giga V; Marinkovic J; Petrovic O; Petrovic M; Stepanovic J; Dobric M; Vukcevic V; Stankovic G; Seferovic P; Ostojic M; Vujisic-Tesic B
    J Am Soc Echocardiogr; 2013 Jul; 26(7):775-82. PubMed ID: 23643850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.
    Tesic M; Seferovic J; Trifunovic D; Djordjevic-Dikic A; Giga V; Jovanovic I; Petrovic O; Marinkovic J; Stankovic S; Stepanovic J; Ristic A; Petrovic M; Mujovic N; Vujisic-Tesic B; Beleslin B; Vukcevic V; Stankovic G; Seferovic P
    J Cardiol; 2017 Oct; 70(4):323-328. PubMed ID: 28336204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No reflow-like pattern in intramyocardial coronary artery suggests myocardial ischemia in patients with hypertrophic cardiomyopathy.
    Kim WS; Minagoe S; Mizukami N; Zhou X; Yoshinaga K; Takasaki K; Yuasa T; Kihara K; Hamasaki S; Otsuji Y; Kisanuki A; Tei C
    J Cardiol; 2008 Aug; 52(1):7-16. PubMed ID: 18639772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary flow reserve impairment in apical vs asymmetrical septal hypertrophic cardiomyopathy.
    Ahn HS; Kim HK; Park EA; Lee W; Kim YJ; Cho GY; Park JH; Sohn DW
    Clin Cardiol; 2013 Apr; 36(4):207-16. PubMed ID: 23378014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging.
    Boonyasirinant T; Rajiah P; Setser RM; Lieber ML; Lever HM; Desai MY; Flamm SD
    J Am Coll Cardiol; 2009 Jul; 54(3):255-62. PubMed ID: 19589439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of myocardial bridging in patients with hypertrophic cardiomyopathy.
    Sharzehee M; Chang Y; Song JP; Han HC
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1282-H1291. PubMed ID: 31674812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
    Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
    Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of coronary CT angiography in outpatients with hypertrophic cardiomyopathy presenting with angina symptoms.
    Shariat M; Thavendiranathan P; Nguyen E; Wintersperger B; Paul N; Rakowski H; Crean AM
    J Cardiovasc Comput Tomogr; 2014; 8(6):429-37. PubMed ID: 25467830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a
    Sciagrà R; Calabretta R; Cipollini F; Passeri A; Castello A; Cecchi F; Olivotto I; Pupi A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):866-875. PubMed ID: 28050630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.